EMA/PE/0000240529 - paediatric investigation plan

cagrilintide

semaglutide

Key facts

• Active substance:
  • cagrilintide
  • semaglutide
• Therapeutic area:
  Metabolism and nutrition disorders
• Decision number:
  EMA/PE/0000240529
• PIP number:
  EMA/PE/0000240529
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of obesity
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  15/05/2025
• Compliance check done:
  No

Decision

EMA/PE/0000240529 : EMA decision of 15 May 2025 on the acceptance of a modification of an agreed paediatric investigation plan for cagrilintide, semaglutide

Adopted Reference Number: EMADOC-1700519818-2117497